Abstract
Aminoazo dyes and other hepatocarcinogenic substances inhibit glucocorticoid-mediated induction of adaptive enzymes, including tyrosine aminotransferase (TAT), in the liver of mice and rats. There is a specific relationship between the effect of a carcinogen on TAT induction and its liver carcinogenicity in animals. If the presumption that tumors are caused not by the chemicals employed but their metabolically activated derivatives is correct, the question arises whether TAT induction is inhibited by carcinogen metabolites or the initial compounds. The goal of this paper is to shed some light on the issue. Mice strains differing in sensitivity to both the carcinogenic and antiglucocorticoid (inhibits TAT induction) effects of the mouse-specific carcinogen ortho-aminoazotoluene (OAT) underwent a set of experimental procedures: ablation of sex and adrenal glands, administration of inhibitors (CoCl2 and pentachlorophenol) or inducers (3,4-benzopyrene, Aroclor 1254, and 20-methylcholanthrene) of xenobiotic-metabolizing enzyme activities, etc. The results unequivocally confirm that glucocorticoid induction of TAT activity in the mouse liver is inhibited by the activated OAT metabolite(s) rather than its initial molecules. In contrast, nonspecific genotoxic agents such as cyclophosphamide and cisplatin exert no effect on TAT induction by glucocorticoids. The wide occurrence (practically in each TAT-expressing hepatocyte) and rapidly reversible inhibition of the enzyme induction by the carcinogen point to the epigenetic nature of this phenomenon.
Similar content being viewed by others
References
Andersen, R.A., Raina, P.N., and Milholland, R.J., Altered responses to cortisol in precancerous liver, Oncologia, 1966, vol. 20, pp. 153–166.
Baginskaya, N.V., Il’nitskaya, S.I., Nikitenko, E.V., and Kaledin, V.I., Promoting effect of o-aminoazotoluene on hepatocarcinogenesis is accompanied by the increase in inflammatory and proliferative processes in liver tissue and decrease in the concentration of free thyroxin in the blood, Bull. Exp. Biol. Med., 2007, vol. 144, pp. 821–824.
Delclos, K.B., Miller, E.C., Miller, J.F., and Liem, A., Sulfuric acid esters as major ultimate electrophilic metabolites of 4-aminoazobenzene and its N-methyl derivatives in infant male C57BL/6J × C3H/HeJ F1 (B6C3F1) mice, Carcinogenesis, 1986, vol. 7, pp. 277–287.
Hamilton, J.W., Louis, C.A., Doherty, K.A., Hunt, S.R., Reed, M.J., and Treadwell, M.D., Preferential alteration of inducible gene expression in vivo by carcinogens that induce bulky DNA lesions, Mol. Carcinog., 1993, vol. 8, pp. 34–43.
Horikoshi, N., Tashiro, F., Tanaka, N., and Ueno, Y., Modulation of hormonal induction of tyrosine aminotransferase and glucocorticoid receptor by aflatoxin B1 and sterigmatocystin in Reuber hepatoma cells, Cancer Res., 1988, vol. 48, pp. 5188–5192.
Kaledin, V.I. and Il’nitskaya, S.I., Metabolic inhibition stimulates and metabolic activation inhibits the carcinogenic effect of o-aminoazotoluene on the liver of mice, Vopr. Onkol., 2011, vol. 7, pp. 216–220.
Kaledin, V.I. and Zakharova, N.P., Effect of hepatocarcinogens on the hormonal induction of tyrosine aminotransferases in the liver of sensitive and resistant animals, in Issledovaniya po induktsii i metastazirovanyu zlokachestvennykh opukholei u eksperimental’nykh zhivotnykh (Studies on the Induction and Metastasis of Malignant Tumors in Experimental Animals), Novosibirsk: ITsiG, 1984, pp. 146–185.
Kaledin, V.I., Glazko, T.T., and Zakharova, N.P., Disruption of tyrosine aminotransferase induction by hydrocortisone in the livers of mice which had received o-aminoazotoluene, Dokl. AN SSSR, 1979, vol. 244, pp. 233–237.
Kaledin, V.I., Serova, I.A., Tsellarius, Yu.G., Semenova, L.A., and Alekseeva, G.V., Interline differences in the frequency of spontaneous and o-aminoazotolueneinduced tumors in mice, in Issledovaniya po induktsii i metastazirovanyu zlokachestvennykh opukholei u eksperimental’nykh zhivotnykh (Studies on the Induction and Metastasis of Malignant Tumors in Experimental Animals), Novosibirsk: ITsiG, 1984, pp. 98–123.
Kaledin, V.I., Gulyaeva, L.F., Vavilin, V.A., Makarova, S.M., Morozkova, T.S., and Rikhter, V.A., Activity of xenobiotic metabolism enzymes in the liver of mice of strains that are sensitive (SWR and S3NA) and resistant (AKR and CC57BR) to the hepatocarcinogenic effect of oaminoazotoluene, Eksp. Onkol., 1999, vol. 21, pp. 18–23.
Kaledin, V.I., Pakharukova, M.Yu., Pivovarova, E.N., Kropachev, K.Yu., Baginskaya, N.V., Vasil’eva, E.D., Il’nitskaya, S.I., Nikitenko, E.V., Kobzev, V.F., and Merkulova, T.I., Correlation between hepatocarcinogenic effect of estragole and its influence on glucocorticoid induction of liver-specific enzymes and activities of FOXA and HNF4 transcription factors in mouse and rat liver, Biochemistry (Moscow), 2009, vol. 74, pp. 377–384.
Kaledin, V.I., Il’nitskaya, S.I., and Baginskaya, N.V., Inhibitory effect of o-aminoazotoluene on the hepatocarcinogenic action of diethylnitrosamine in a combined application in mice, Vopr. Onkol., 2010, vol. 56, no. 2, pp. 196–200.
Kizer, D.E., Cox, B., Howel, B.A., and Shirley, B.C., Effect of hepatocarcinogens on hepatocyte DNA synthesis and cortisone induction of tryptophane oxygenase, Cancer Res., 1969, vol. 29, pp. 2039–2046.
Kropachev, K.Yu., Kaledin, V.I., Kobzev, V.F., Timofeeva, O.A., Ilnitskaya, S.I., Vasilyeva, E.D., Plisov, C.Y., Richkova, N.A., Filipenko, M.L., and Merkulova, T.I., Involvement of transcription factor HNF3γ in the effect of o-aminoazotoluene on glucocorticoid induction of tyrosine aminotransferase in mice sensitive to its hepatocarcinogenic action, Mol. Carcinog., 2001, vol. 31, pp. 10–15.
Merkulova, T.I., Kropachev, K.Yu., Timofeeva, O.A., Vasiliev, G.V., Levashova, Z.B., Ilnitskaya, S.I., Kobzev, V.F., Pakharukova, M.Y., Bryzgalov, L.O., and Kaledin, V.I., Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and orthoaminoazotoluene in mouse and rat liver, Mol. Carcinog., 2005, vol. 44, pp. 223–232.
Mikhailova, O.N., Vasyunina, E.A., Ovchinnikova, L.P., Timofeeva, O.A., Filipenko, M.L., and Kaledin, V.I., o-Aminoazotoluene does induce the enzymes of its own metabolism in mouse liver, Toxicology, 2005, vol. 211, pp. 132–138.
Miller, M.S., Buzard, G.S., and McDowell, A.E., In vivo inhibition of glucocorticoid-inducible gene expression by dimethylnitrosamine in rat liver, Biochem. Pharmacol., 1993, vol. 45, pp. 1465–1470.
Morozkova, T.S., Zhukova, N.A., Semenov, D.E., and Popova, N.A., PT/Y mice are sensitive to the inhibitory effect of o-aminoazotoluene on glucocorticoid induction of tyrosine aminotransferase and its hepatocarcinogenic effect, Bull. Exp. Biol. Med., 2014, vol. 158, no. 12, pp. 757–761.
Ohmi, R., Bhargava, M., and Arias, I.M., Binding of 3'-methyl-N,N-dimethyl-4-aminoazobenzene metabolites to rat liver cytosol proteins and ligandin subunits, Cancer Res., 1981, vol. 41, pp. 3461–3464.
Ovchinnikova, L.P., Bogdanova, L.A., and Kaledin, V.I., Mutagenic activation reduces carcinogenic activity of ortho-aminoazotoluene for mouse liver, Bull. Exp. Biol. Med., 2012, vol. 154, no. 11, pp. 623–628.
Testa, B. and Jenner, P., Inhibitors of cytochrome P450s and their mechanism of action, Drug Metab. Rev., 1981, vol. 12, pp. 1–117.
Timofeeva, O.A., Eremeev, A.V., Goloshchapov, A., Kalashnikova, E., Ilnitskaya, S.I., Setkov, N.A., Kobzev, V.F., Buzard, G.S., Filipenko, M.L., Kaledin, V.I., and Merkulova, T.I., Effect of o-aminoazotoluene on liver regeneration and p53 activation in mice susceptible and resistant to hepatocarcinogenesis, Toxicology, 2008, vol. 254, pp. 91–96.
Turusov, V.S., Belitskii, G.A., Pylev, L.N., and Koblyakov, V.A., Mechanisms of action and classification of chemical carcinogens, in Kantserogenez (Carcinogenesis), Moscow: Meditsina, 2004, pp. 204–225.
Vilenchik, M.M., Zakonomernosti molekulyarno-geneticheskogo deistviya khimicheskikh kantserogenov (Patterns of Molecular Genetic Action of Chemical Carcinogens), Moscow: Nauka, 1977.
Warwick, G.P. and Roberts, J.J., Persistent binding of butter yellow metabolites to rat liver DNA, Nature, 1967, vol. 215, pp. 1206–1207.
Wogan, G.N. and Friedman, M.A., Inhibition by aflatoxin B1 of hydrocortisone induction of rat liver tryptophan pyrrolase and tyrosine aminotransferase, Arch. Biochem. Biophys., 1968, vol. 128, pp. 509–516.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.I. Kaledin, S.I. Ilnitskaya, N.A. Popova, O.A. Koval, I.A. Pyshnaya, L.F. Gulyaeva, 2015, published in Vavilovskii Zhurnal Genetiki i Selektsii, 2015, Vol. 19, No. 1, pp. 136–143.
Rights and permissions
About this article
Cite this article
Kaledin, V.I., Ilnitskaya, S.I., Popova, N.A. et al. Induction of tyrosine aminotransferase in mice is inhibited by the activated metabolites of ortho-aminoazotoluene. Russ J Genet Appl Res 6, 91–98 (2016). https://doi.org/10.1134/S207905971601007X
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S207905971601007X